LENZ Therapeutics (LENZ) executive compensation, 2026 proxy

Evert Schimmelpennink, President and Chief Executive Officer, was paid $7M in 2025, up 1% from $7M the year before.

Filed
April 28, 2026
Annual meeting
June 12, 2026
Pay year
2025
Named executives
3
CEO total pay
$7M+1% vs prior year
CEO 2025 Salary
$690,000Base salary for the year
CEO Target Bonus
60%Percentage of base salary
Bonus Payout Percentage
130%Achievement level determined by committee

How Schimmelpennink was paid

$7M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary10%Option awards82%Non-equity incentive8%All other compensation0%

Named executive officers

ExecutiveTotal
Evert SchimmelpenninkPresident and Chief Executive Officer$7,036,009
Marc OdrichChief Medical Officer$2,436,788
Shawn OlssonChief Commercial Officer$2,387,388

What changed and why

  • $7MEvert Schimmelpennink received a total compensation of $7,036,009 in 2025 compared to $6,983,510 in 2024.
  • 130%The compensation committee determined corporate performance goals were exceeded and achieved at 130% of target.
  • 60%Evert Schimmelpennink's base salary for 2025 was $690,000 and his target annual cash bonus was 60%.
  • $2.4MMarc Odrich received a total compensation of $2,436,788 in 2025.
  • $2.4MShawn Olsson received a total compensation of $2,387,388 in 2025.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.